The Quiet Withdrawal
Regional hospice chains across the country are walking away from Medicaid managed care contracts, and they are doing it without press releases or public statements. The exits are happening incrementally – one contract at a time, one county at a time – but the cumulative effect is becoming visible to anyone tracking network adequacy filings and state Medicaid enrollment data. What looked like isolated business decisions six months ago now looks like a coordinated retreat.
The mechanics are straightforward. Managed care organizations contract with hospice providers to deliver end-of-life care to Medicaid beneficiaries at negotiated rates, which are almost always below fee-for-service reimbursement. Regional chains, which operate across multiple counties or states and carry the overhead costs that small independent providers do not, have been running the numbers and finding those rates increasingly unworkable. When a contract comes up for renewal, more of them are simply declining to sign.
This is not a crisis that announces itself loudly.
Why the Math Stopped Working
Hospice care is labor-intensive by definition. It requires nurses, social workers, chaplains, home health aides, and physicians, all coordinating around patients who need continuous attention during the final months of life. Staffing costs have risen sharply since 2021 and have not come back down, particularly for registered nurses and specialized palliative care staff in rural and suburban markets. When managed care reimbursement rates were set two or three years ago, they reflected a different cost environment. Renegotiating those rates with managed care organizations is possible in theory, but in practice, large insurers hold significant leverage and have little incentive to move.
The problem is compounded by administrative burden. Managed care contracts impose prior authorization requirements, utilization reviews, and documentation protocols that fee-for-service Medicare does not. A hospice serving 200 Medicaid managed care patients may need dedicated billing and compliance staff just to manage those contracts, staff that would not be necessary if those same patients were covered under traditional Medicaid or Medicare. For regional chains trying to control overhead, that administrative drag has a real dollar figure attached to it.
There is also a strategic dimension that goes beyond quarterly margins. Regional hospice chains have spent the past several years under significant pressure from private equity-backed national operators entering their markets. Competing on price is difficult when a national competitor can absorb short-term losses to capture market share. Some regional operators appear to be concentrating their capacity on higher-margin Medicare and private-pay patients as a way of staying financially stable rather than chasing Medicaid volume that does not cover costs.
Who Gets Left Behind
When a regional chain exits a managed care contract, the managed care organization is technically still obligated to provide network coverage to its members. In practice, that often means scrambling to contract with whoever remains – smaller independent agencies, nonprofit hospices, or providers located farther from where patients actually live. Network adequacy standards exist at the state level, but enforcement is inconsistent, and “adequate” on paper can mean travel distances or wait times that make timely hospice enrollment genuinely difficult for patients and families.
The populations most affected are not evenly distributed. Medicaid managed care hospice patients tend to be lower-income, more likely to live in rural or semi-rural areas, and more likely to have conditions like dementia or heart failure rather than cancer – conditions where the transition to hospice is less clearly defined and requires more proactive care coordination. These are also patients who are least likely to have family members with the time, knowledge, or resources to navigate a fragmented network on their behalf during an already devastating period.
State Medicaid agencies are aware of the trend, and a handful have begun reviewing their managed care contracts to assess whether hospice carve-outs – removing hospice from managed care altogether and returning it to fee-for-service administration – might stabilize provider participation. A few states have already moved in that direction quietly, though comprehensive data on outcomes from those transitions is still limited. The underlying tension is that managed care was supposed to improve care coordination and reduce costs, but in a specialty as narrow as hospice, the managed care model may simply not generate the efficiencies it produces elsewhere.
What Comes Next
The exits are unlikely to stop. As long as Medicaid managed care rates lag behind actual cost growth and administrative burdens remain high, the calculus for regional operators will keep pointing toward the same conclusion. The contracts that make the least sense financially will be the first to go, and in hospice, those contracts tend to cover the patients with the fewest options and the least time to find alternatives. A managed care organization that loses its largest regional network partner in a given market does not replace that coverage overnight – and the gap it leaves is measured not in delayed appointments but in patients dying at home without adequate pain management or family support, because the provider who was supposed to be there decided the contract was not worth renewing.
